Berkshire Money Management Inc. Invests $28,000 in iShares Biotechnology ETF $IBB

Berkshire Money Management Inc. bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 220 shares of the financial services provider’s stock, valued at approximately $28,000.

Several other large investors have also added to or reduced their stakes in IBB. Brighton Jones LLC bought a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $201,000. GAMMA Investing LLC raised its stake in iShares Biotechnology ETF by 12,698.7% during the first quarter. GAMMA Investing LLC now owns 48,251 shares of the financial services provider’s stock valued at $6,171,000 after buying an additional 47,874 shares during the last quarter. SeaCrest Wealth Management LLC boosted its holdings in iShares Biotechnology ETF by 37.0% in the first quarter. SeaCrest Wealth Management LLC now owns 4,428 shares of the financial services provider’s stock worth $566,000 after acquiring an additional 1,195 shares in the last quarter. Pines Wealth Management LLC increased its holdings in shares of iShares Biotechnology ETF by 19.4% during the first quarter. Pines Wealth Management LLC now owns 2,855 shares of the financial services provider’s stock valued at $365,000 after acquiring an additional 464 shares in the last quarter. Finally, KFG Wealth Management LLC raised its holdings in iShares Biotechnology ETF by 8.8% in the first quarter. KFG Wealth Management LLC now owns 2,332 shares of the financial services provider’s stock worth $298,000 after buying an additional 189 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $151.00 on Monday. iShares Biotechnology ETF has a twelve month low of $107.43 and a twelve month high of $151.62. The firm has a 50 day moving average of $139.19 and a 200 day moving average of $129.95.

iShares Biotechnology ETF Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.0828 per share. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 annualized dividend and a yield of 0.2%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.